Foz do Iguaçu to establish clinical criteria for public access to tirzepatide

The municipality of Foz do Iguaçu is developing technical guidelines to regulate the potential inclusion of tirzepatide (Mounjaro) in its public health system (SUS). This initiative marks an early-stage effort to manage the high demand and costs associated with GLP-1 receptor agonists at the local government level.